Cytokines in the sera of patients with pemphigus vulgaris: Interleukin-6 and tumour necrosis factor-alpha levels are significantly increased as compared to healthy subjects and correlate with disease activity

European Cytokine Network

Volumn 8, Issue 4, 1997, Pages 383-387

  D'Auria, Luciano ^a   Bonifati, Claudio ^a   Mussi, Anna ^a   D'Agosto, Giovanna ^a   De Simone, Clara ^b   Giacalone, Bernardino ^a   Ferraro, Carmela ^a   Ameglio, Franco ^a  

^a SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Blister; Cytokines; Pemphigus vulgaris; Serum

Indexed keywords

CORTICOSTEROID; CYTOKINE; INTERLEUKIN 6; METHYLPREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PEMPHIGUS VULGARIS;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; PEMPHIGUS; REFERENCE VALUES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031435327     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Delaporte E, Bieber T, Viac J, Faure M, Nicolas J F. 1994. Cytokines épidermiques et inflammation cutanée. Ann. Dermatol Venereal. 121: 836.
2. Bonifati C, Carducci M, Cordiali-Fei P, Trento E, Sacerdoti G, Fazio M, Ameglio F. 1994. Correlated increases of tumor necrosis factor-alpha, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients-relationships with disease severity. Clin. Exp. Dermatol. 19: 383.
3. Gomi T, Shiohara T, Munakata T, Imanishi K, Nagashima M. 1991. Interleukin-alphal, tumor necrosis factor-alpha and interferon-gamma in psoriasis. Arch. Dermatol. 127: 827.
4. Stanley John R. "Pemphigus" in "Dermatology in general medicine", Fitzpatrick T B, Eisen A Z, Wolff K, Freedberg I M, Austen K F. Chap. 52, p. 606. 1993, 4th Edition, McGraw-Hill, Inc. Healt Professions Division.
5. Goldstein S M, Wintroub B U. "Dermatologic disease" in "Basic and clinical immunology", Stites D P, Terr A I, Parslow T G. Chap. 37, p. 500. Prentice-Hall International Inc., 1994 Appleton & Lange.
6. Lever W F, Schaumburg-Lever G. "Noninfectious vesicular and bullous diseases" in Histopathology of the skin, Philadelphia: Lippincott J B, 7th edition 1990; p. 116.
7. D'Auria L, Cordiali-Fei P, Pietravalle M, Ferraro C, Mastroianni A, Bonifati C, Giacalone B, Ameglio F. 1997. The serum levels of sE-selectin are increased in patients with bullous pemphigoid or pemphigus vulgaris. Correlation with the number of skin lesions and recovery after corticosteroid therapy. Br. J. Dermatol. 137: 59.
8. Kiistala U, Mustakallio K K. 1967. Dermoepidermal separation with suction. Electron microscopic and histochemical study of initial events of blistering of human skin. J. Invest. Dermatol. 48: 466.
9. Ameglio F, D'Auria L, Bonifati C, Ferraro C, Mastroianni A, Pietravalle M, Giacalone B. 1997. Blister fluid and serum concentrations of different cytokines in patients with bullous pemphigoid. Int. J. Immunopathol. Pharmacol. 10: 97
10. Ameglio F, Bonifati C, Pietravalle M, Fazio M. 1994. Interleukin-6 and tumor necrosis factor levels decrease in the suction blister fluids of psoriatic patients during effective therapy. Dermatology 189: 359.
11. Kuwabara H, McVittie E, Hunter J A A, Uda H, Yamauchi A, Sakamoto H. 1996. Expression of mRNA of tumor necrosis factor-alpha and interleukin-6 in bullous pemphigoid skin. Eur. J. Dermatol. 6: 300.
12. Aggarwal B B, Natarajan K. 1996. Tumor necrosis factors: developments during the last decade. (Review) Eur. Cytokine Netw. 7: 93.
13. Brach M A, Herrmann R. 1992. Interleukin-6: present and future. (Review) Int. J. Clin. Lab. Res. 22: 143.
14. Platel D, Guiguet M, Briere F, Bernard A, Mack G. 1994. Human interleukin-6 acts as a co-factor for the up-regulation of C3 production by rat liver epithelial cells. Eur. Cytokine Netw. 5: 405.
15. Groves R W, Allen M H, Ross E L, Barker J N, Mac Donald D M. 1995. Tumor necrosis factor-alpha is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expression. Br. J. Dermatol. 132: 345.
16. Wintroub B U, Mihm M C, Goetzl E J, Soter N A, Ausren K F. 1978. Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid. N. Engl. J. Med. 8: 417.
17. Chorzelski T P, Jablonska S, Beutner E H. Bullous pemphigoid: relationship of immunopathology to clinical findings, p. 337 in "Immunopathology of the skin", Beutner E H, Chorzelski T P, Vijay K. 3rd edition, 1987, a Wiley Medical Publication John Wiley & Sons New York-Chichester-Brisbane-Toronto-Singapore.
18. Monacelli M, Nazzaro P. "Dermatosi del gruppo Pemfigo" in Dermatologia e Venereologia, Monacelli M, Nazzaro P. 1967, p. 545. Casa Editrice Dr. Francesco Vallardi, Societa' Editrice Libraria SpA, Milano.